In a pioneering achievement, the Saudi Food and Drug Authority (SFDA) launched in 2023 the world's first regulatory mechanism that leverages artificial intelligence (AI) to actively reduce pharmaceutical risks.
Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has received FDA 510(k) clearance for the use of its DEXTER Robotic Surgery System in adult cholecystectomy (gallbladder removal).
Clarius Mobile Health, a leader in AI-powered handheld ultrasound, today announced FDA clearance of Clarius Median Nerve AI—an artificial intelligence tool that automates median nerve measurements to accelerate and standardize the diagnosis of carpal tunnel syndrome (CTS). The new tool, integrated in Clarius handheld ultrasound devices, is being showcased at the American College of Sports Medicine (ACSM) Annual Meeting in Atlanta from May 27-30, 2025.
Human in Motion Robotics is proud to announce that XoMotion, the world's most advanced self-balancing exoskeleton, has been named a 2025 TAG Awards Winner for MedTech Innovation.
This research aims to improve assistive robotics for dyspraxia, focusing on real-time adaptation to individual needs through advanced mathematical modeling.
Researchers unveil the fractal globule structure of DNA, providing new insights into genome organization and its implications for gene regulation and disease.
This AI tool analyzes Instagram data to create sentiment maps, helping city officials understand public emotions and improve urban safety and services.
The AI model developed for atopic dermatitis assessment uses smartphone photos, bridging the gap between patient-reported symptoms and clinical evaluation.
OmniMD unveils AI Clinicians; a bold leap into the future of healthcare. Designed to think like a physician and act faster than one, AI Clinicians combine clinical intelligence, predictive analytics, and real-time decision support to transform how care is delivered.
A new AI model developed by researchers at the Eric and Wendy Schmidt Center at the Broad Institute and ETH Zurich's Department of Health Science and Technology can identify genes that have been altered, such as ones that might be causing a disease, in a cell just by analyzing an image of the cell's chromatin — the dense package of chromosomes inside the cell's nucleus.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.